Dr. Shuibing Chen discusses the advantages of organoids, surprising discoveries in COVID research and her hopes for revolutionizing the future of drug therapies
Learn how the latest proteomics technology is driving large-scale, high-throughput studies in disease biology
Watch this on-demand webinar to find out more about the advantages and challenges of adopting 3D cell culturing
In vitro studies reveal the underlying biology of bone repair to inform translational medicine
Top talks and resources exploring the latest research and methods in the field are now available on demand
An insider’s look into the bottlenecks and challenges associated with manufacturing and supply chain workflows within lateral flow diagnostics
Dr. Jacqueline Barnett and Dr. Joel Allainguillaume discuss their work to develop handheld detectors to combat the spread of cacao swollen shoot virus and arrest the decline in the cocoa industry
Learn how Massachusetts General Hospital research lab is using plasma proteomics to enhance immunotherapy for melanoma
Explore topics such as size-exclusion chromatography and protein reversed-phase LC-MS to antimicrobial susceptibility testing and biobank optimization
Elecsys Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS- CoV-2 spike protein
Flow cytometry innovator’s cFluor Reagents now packaged together as a simplified solution for multicolor panels
Watch this on-demand webinar to find out how targeting B-cell maturation antigen and GPRC5D simultaneously could help to prevent tumor cell escape
Explore ways to improve time to result in critical pathways such as sepsis
Watch this on-demand webinar to learn more about new updates of the NanoDrop One platform
From immunoassays and ELISAs to multi-mode microplate readers, discover the technologies making a difference for other scientists in your field
Explore the applications and benefits of ambient ionization for biomedical research and its future potential for pharma and food industries
In a 17-4 vote, the FDA vaccine advisory committee recommended that Pfizer/BioNTech’s COVID-19 vaccine should be distributed to the U.S.
Parties to collaborate on development, commercialization, and supply of the Orgenesis therapies pipeline
